MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
Janux Therapeutics, Inc. Common Stock

JANX

#2192
Janux Therapeutics, Inc. Common Stock
13.61
+0.59%
Sector:
Base:
Profit Currency:
Daily Range
13.61
13.61
Year Range
12.12
35.25
Daily Change
+0.59%
Monthly Change
-7.60%
6 month change
-42.31%
Year Change
-57.99%
Previous Close
13.53
Open
13.61
Bid
Ask
Low
13.61
High
13.61
Volume
116
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. JANX
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value 20212022202320242025 TTM

News

Investing Investing
JANX
2026.02.17
Janux therapeutics doses first participant in JANX011 phase 1 trial
Seeking Alpha Seeking Alpha
VIR JANX
2026.02.06
Vir Biotechnology Stock: The Low-Down On The Readouts Ahead (NASDAQ:VIR)
Zacks Zacks
JANX
2026.02.03
Wall Street Analysts See a 319.23% Upside in Janux Therapeutics (JANX): Can the Stock Really Move This High?
Investing Investing
JANX
2026.01.26
Janux Therapeutics appoints William Go as new chief medical officer
Seeking Alpha Seeking Alpha
BMY JANX
2026.01.23
Bristol-Myers Squibb: Solid Tumor Collaboration With Janux And Camzyos Expansion (BMY)
Zacks Zacks
BMY FOLD KROS JANX
2026.01.23
JANX Enters Global Oncology Collaboration With BMY, Stock Rises
Investing Investing
BMY JANX
2026.01.22
Janux stock rises after Bristol Myers Squibb collaboration deal
Benzinga Benzinga
JANX BMY MRK
2026.01.22
Janux Therapeutics Strikes Bristol Myers Biotech Deal Worth $800 Million - Janux Therapeutics (NASDAQ:JANX)
Investing Investing
JANX
2026.01.22
Janux, Bristol Myers Squibb partner on tumor-activated therapy
Investing Investing
JANX
2026.01.20
Clear Street downgrades Janux Therapeutics stock to Hold on efficacy concerns
Investing Investing
JANX
2026.01.03
Maria Dobek, Janux Therapeutics VP, sells $20k in shares
Investing Investing
JANX
2026.01.03
Janux Therapeutics’ CMO McIver sells $37k in shares

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Market
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd